Liver Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Diagnosis Technique (Imaging, Laboratory Tests, Endoscopy, Biopsy, Others); By End-Use (Hospitals, Laboratories, Others), By Regions; Segment Forecast, 2021 - 2028
- 发布日期：3月2021年
- Pages: 108
- Format: PDF
- Report ID: PM1810
- Base Year: 2020
- Historical Data: 2016 - 2019
Report Summary
The global liver disease diagnostics market was valued at USD 30.59 billion in 2020 and is expected to grow at a CAGR of 6.7% during the forecast period. A global rise in acute and chronic liver disorders is the most prominent factor responsible for the market growth for liver disease diagnostics. For instance, as per the estimates of the World Health Organization (WHO), in 2018, there were around 841,080 new cases of liver cancer and approximately 781,631 people died with it.
Moreover, advancements in rapid tests by the key players in the liver disease diagnostics market for a specific section of the population such as HIV-positive patients and pregnant women also boosted the market growth. In line with this, Abbott Labs, in February 2019, received a CE mark for its HBsAg 2 test. It is an easy-to-use, rapid test for the detection of hepatitis B in the market.
Know more about this report:请求样本页面
行业动态
增长司机
Rising research & development spend towards accurate and early diagnosis for better patient outcomes have propelled the market growth for liver disease diagnostics. Key players in the market for liver disease diagnostics are focused on introducing innovative products and services to improve diagnosis time. In this line, in 2020, Roche Ltd received breakthrough device designation for its Elecsys GALAD product. The product was developed by the Roche Diagnostics Liver indication program to enhance diagnosis workflow and much-needed help for the healthcare practitioners to provide accurate information.
Moreover, the introduction of novel procedures to diagnose liver diseases is also likely to have a positive impact on the future growth of the market for liver disease diagnostics. Earlier, in 2017, Ortho Clinical Diagnostics developed a new innovative method for the measurement of Alanine Aminotransferase (ALT) using VITROS ALTV Slides, developed through dry slide technology. This new method has reduced the sample requirement, increased sensitivity, and enhanced diagnostics capabilities.
肝病诊断市场报告范围
该市场主要基于诊断技术，最终用途和地区进行分段。
By Diagnosis Technique |
通过最终使用 |
By Region |
|
|
|
Know more about this report:请求样本页面
诊断技术洞察力
In 2020, the imaging market segment held the liver disease diagnostics industry share, among all. Such a high share is attributed to an increasing number of strategic initiatives taken by key players in the marketplace to launch advanced imaging services. First lab tests are carried out using blood, and fluid samples to diagnose abnormalities in liver functioning. WhileCT扫描，MRI和超声波是对诊断的非侵入性技巧。
最终用途的洞察
2020年，医院市场分部占全球肝病诊断行业的最大份额。这一高度归因于大多数患者依赖医院的事实，因为它们更好地配备了疾病诊断能力。医院还向患者提供最佳护理，使早期疾病诊断能够。此外，医疗保健基础设施的进一步进步也提升了分部的增长前景。yabo娱乐vip
The laboratory market segment is projected to grow at the fastest growth rate over the assessment period of the liver disease diagnostics market. Several labs and institutes have introduced awareness initiatives to diagnose hepatic abnormalities. For instance, in 2017, Mylan Labs collaborated with the Delhi-based Institute of the liver and Biliary Sciences to carry out awareness programs. The collaboration aimed to provide appropriate disease screening and testing capabilities to over 1,000 patient-based in Delhi. It also carried out tests for Hepatitis B and C, and ALT.
地理概述
地理上，全球肝病诊断市场被分叉进入北美，亚太地区，欧洲，拉丁美洲和中东和非洲。北美是欧洲和亚太地区之后最大的收入贡献者。2019年，北美地区占全球肝病诊断市场的43％以上。
预计北美将在评估期内保持其优势。促进此类增长的区域因素包括研究与开发的主要参与者的高投资。该地区有许多组织提供有关疾病诊断信息，还预计将促进该地区对肝病诊断的市场增长。例如，该区域具有GetPalliativeCare.org，其涉及与CT扫描，活组织检查和内窥镜检查相关的姑息治疗举措。
Competitive Insight
肝病诊断市场中的主要球员正在实施众多战略，以开发创新技术，以提高患者以患者为中心的护理。在肝病诊断工业中运营的着名球员是Horiba Medical，Abbott，Fujifilm Corporation，Ranche Ltd，Randox Laboratories Ltd.，波士顿科学公司，Americo Fisher Scientific Inc.，America Holdings，Siemens Healthcare GmbH。yabo娱乐vip
